Biophytis Announces the Signature of a Master Service Agreement With Intsel Chimos, a Pharmaceutical Company That Will Operate Sarconeos (BIO101) in France for the Treatment of Severe Forms of COVID-19 – Yahoo Finance

Biophytis and Intsel Chimos signed a master service agreement under which Intsel Chimos will be the operating pharmaceutical company/exploitant, partner and distributor in France for the drug Sarconeos (BIO101) developed by Biophytis in the context of the early access program application.The application request for early access program, currently underway with the Haute Autorité de Santé […]

Continue reading

What we know about the origin of covid-19, and what remains a mystery – The Washington Post

Sign inThe precise origin of SARS-CoV-2, the coronavirus that causes covid-19, remains unknown and continues to be a source of contentious debate. Two theories dominate the conversation: a natural spillover from infected animals, and a “lab leak” associated with coronavirus research in Wuhan, China, the city where the first cases of an unusual pneumonia-like illness […]

Continue reading

CDC adds COVID vaccine to routine immunization schedule for kids, adults – The Hill

COVID-19 vaccines are now included among the routine shots recommended by the Centers for Disease Control and Prevention (CDC) for children, adolescents and adults.The 2023 list includes shots for the flu, measles mumps and rubella, polio, and other inoculations.The vaccine schedule represents the current recommendations for people as a regular part of their vaccinations against […]

Continue reading

FDA advisory committee votes unanimously in favor of a one-shot COVID-19 vaccine approach – 5 questions answered – The Conversation

Instructor of Human Immunology, Emory University Matthew Woodruff receives funding from the National Institute of Health and the US Department of Defense to support his academic research.View all partnersThe U.S. Food and Drug Administration’s key science advisory panel, the Vaccines and Related Biological Products Advisory Committee, met on Jan. 26, 2023, to chart a path […]

Continue reading
1 146 147 148 149 150 239